WilmerHale Partner Andre Owens Joins LUNGevity Foundation's Board of Directors

WilmerHale Partner Andre Owens Joins LUNGevity Foundation's Board of Directors

Firm News

This press release was prepared and disseminated by the LUNGevity Foundation.

LUNGevity Foundation, the nation's leading lung cancer-focused nonprofit organization, announced that Andre Owens, partner in the Washington, D.C., law office of WilmerHale, has joined the Board of Directors. Together with other global leaders on the Board, Owens will lend his expertise to further LUNGevity's work of changing outcomes for people with lung cancer.

"We are grateful to have someone as uniquely qualified as Andre join our Board," said Andrea Ferris, CEO of LUNGevity Foundation. "His valuable specialized knowledge coupled with a strong personal motivation for increasing survivorship in lung cancer makes Andre a great addition to help steer the Foundation's research, education, support, and public policy programs."

"Like so many others, I have been personally affected by the loss of loved ones to lung cancer," explains Owens. "While there has been some progress in the lung cancer space, we still have a lot more to do. I am proud and honored to help LUNGevity achieve its vision of creating a world where no one dies of lung cancer." 

Andre's legal practice focuses on securities trading and markets activities. He counsels broker-dealers, securities exchanges, investment advisers, and other clients on a variety of regulatory issues. 

In the past, Andre served as a member of the U.S. Securities and Exchange Commission's Office of General Counsel.  He also served as counsel to former SEC Commissioner Steven M. H. Wallman.

Mr. Owens graduated from Providence College with a bachelor's degree and holds a JD degree from Harvard Law School.

Learn more about the LUNGevity Foundation.

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.